HEADER TRANSPORT PROTEIN 10-OCT-17 6EOY TITLE TRANSTHYRETIN IN COMPLEX WITH 4-(1,3-BENZOTHIAZOL-2-YL)-2- TITLE 2 METHYLANILINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSTHYRETIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ATTR,PREALBUMIN,TBPA; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TTR, PALB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693 KEYWDS TRANSTHYRETIN, AMYLOID, TTR AMYLOID INHIBITOR, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR J.P.LEITE,L.GALES REVDAT 2 17-JAN-24 6EOY 1 REMARK REVDAT 1 06-OCT-21 6EOY 0 JRNL AUTH E.Y.COTRINA,L.M.SANTOS,J.RIVAS,D.BLASI,J.P.LEITE,M.A.LIZ, JRNL AUTH 2 M.A.BUSQUETS,A.PLANAS,R.PROHENS,A.GIMENO,J.JIMENEZ-BARBERO, JRNL AUTH 3 L.GALES,J.LLOP,J.QUINTANA,I.CARDOSO,G.ARSEQUELL JRNL TITL TARGETING TRANSTHYRETIN IN ALZHEIMER'S DISEASE: DRUG JRNL TITL 2 DISCOVERY OF SMALL-MOLECULE CHAPERONES AS DISEASE-MODIFYING JRNL TITL 3 DRUG CANDIDATES FOR ALZHEIMER'S DISEASE. JRNL REF EUR.J.MED.CHEM. V. 226 13847 2021 JRNL REFN ISSN 0223-5234 JRNL PMID 34555615 JRNL DOI 10.1016/J.EJMECH.2021.113847 REMARK 2 REMARK 2 RESOLUTION. 1.38 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.38 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.75 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.990 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.8 REMARK 3 NUMBER OF REFLECTIONS : 48775 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.162 REMARK 3 R VALUE (WORKING SET) : 0.160 REMARK 3 FREE R VALUE : 0.195 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.120 REMARK 3 FREE R VALUE TEST SET COUNT : 2498 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.7750 - 3.6159 0.96 2691 156 0.1780 0.2018 REMARK 3 2 3.6159 - 2.8703 0.98 2609 138 0.1636 0.1810 REMARK 3 3 2.8703 - 2.5075 0.99 2580 165 0.1791 0.2132 REMARK 3 4 2.5075 - 2.2782 0.99 2619 127 0.1577 0.2099 REMARK 3 5 2.2782 - 2.1150 1.00 2586 168 0.1445 0.1751 REMARK 3 6 2.1150 - 1.9903 0.99 2555 134 0.1376 0.1682 REMARK 3 7 1.9903 - 1.8906 0.99 2586 125 0.1289 0.1683 REMARK 3 8 1.8906 - 1.8083 0.99 2566 142 0.1317 0.1805 REMARK 3 9 1.8083 - 1.7387 0.99 2534 137 0.1361 0.1691 REMARK 3 10 1.7387 - 1.6787 0.99 2560 139 0.1382 0.1853 REMARK 3 11 1.6787 - 1.6262 0.99 2576 127 0.1330 0.2143 REMARK 3 12 1.6262 - 1.5797 0.99 2505 148 0.1325 0.1874 REMARK 3 13 1.5797 - 1.5381 0.99 2566 133 0.1429 0.1880 REMARK 3 14 1.5381 - 1.5006 0.99 2565 145 0.1554 0.2133 REMARK 3 15 1.5006 - 1.4665 1.00 2566 128 0.1680 0.2308 REMARK 3 16 1.4665 - 1.4353 0.99 2548 119 0.1823 0.2294 REMARK 3 17 1.4353 - 1.4065 0.99 2536 130 0.1998 0.2494 REMARK 3 18 1.4065 - 1.3800 0.99 2529 137 0.2150 0.2640 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.140 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 18.130 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 18.19 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.35 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 1901 REMARK 3 ANGLE : 0.912 2604 REMARK 3 CHIRALITY : 0.091 292 REMARK 3 PLANARITY : 0.007 329 REMARK 3 DIHEDRAL : 8.568 1050 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: (CHAIN A AND (RESID 10 THROUGH 22 OR REMARK 3 RESID 24 THROUGH 26 OR RESID 28 THROUGH REMARK 3 65 OR RESID 67 THROUGH 69 OR RESID 71 OR REMARK 3 RESID 73 THROUGH 84 OR RESID 86 THROUGH REMARK 3 114 OR RESID 116 THROUGH 118 OR RESID 120 REMARK 3 THROUGH 124)) REMARK 3 SELECTION : (CHAIN B AND (RESID 10 THROUGH 22 OR REMARK 3 RESID 24 THROUGH 26 OR RESID 28 THROUGH REMARK 3 65 OR RESID 67 THROUGH 69 OR RESID 71 OR REMARK 3 RESID 73 THROUGH 84 OR RESID 86 THROUGH REMARK 3 114 OR RESID 116 THROUGH 118 OR RESID 120 REMARK 3 THROUGH 124)) REMARK 3 ATOM PAIRS NUMBER : 900 REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6EOY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-OCT-17. REMARK 100 THE DEPOSITION ID IS D_1200006954. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-MAY-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 4.8-5.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID30B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.973 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : BE CRL LENSES FOR VERTICAL REMARK 200 FOCUSING AND RH/PT/SI COATED REMARK 200 ELLIPITCAL MIRROR FOR HORIZONTAL REMARK 200 FOCUSING REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.5.25 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56993 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.310 REMARK 200 RESOLUTION RANGE LOW (A) : 42.750 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.02600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.31 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 0.73800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDBID 1Y1D REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.35 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.34 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: ACETATE BUFFER 0.2 M PH 4.8-5.4, REMARK 280 AMMONIUM SULFATE 1.8-2.2 M, 7% GLYCEROL, EVAPORATION, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 21.43150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.75450 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.43150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.75450 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -42.86300 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 -85.50900 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 CAB BM8 A 201 LIES ON A SPECIAL POSITION. REMARK 375 CAH BM8 A 201 LIES ON A SPECIAL POSITION. REMARK 375 CAJ BM8 A 201 LIES ON A SPECIAL POSITION. REMARK 375 CAM BM8 A 201 LIES ON A SPECIAL POSITION. REMARK 375 NAQ BM8 A 201 LIES ON A SPECIAL POSITION. REMARK 375 CAH BM8 B 201 LIES ON A SPECIAL POSITION. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASN A 124 O REMARK 470 ASN B 124 O REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 21 CZ NH1 NH2 REMARK 480 GLU A 61 CD OE1 OE2 REMARK 480 GLU A 62 CD OE1 OE2 REMARK 480 GLU A 63 CD OE1 OE2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BM8 A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BM8 B 201 DBREF 6EOY A 10 124 UNP P02766 TTHY_HUMAN 30 144 DBREF 6EOY B 10 124 UNP P02766 TTHY_HUMAN 30 144 SEQRES 1 A 115 CYS PRO LEU MET VAL LYS VAL LEU ASP ALA VAL ARG GLY SEQRES 2 A 115 SER PRO ALA ILE ASN VAL ALA VAL HIS VAL PHE ARG LYS SEQRES 3 A 115 ALA ALA ASP ASP THR TRP GLU PRO PHE ALA SER GLY LYS SEQRES 4 A 115 THR SER GLU SER GLY GLU LEU HIS GLY LEU THR THR GLU SEQRES 5 A 115 GLU GLU PHE VAL GLU GLY ILE TYR LYS VAL GLU ILE ASP SEQRES 6 A 115 THR LYS SER TYR TRP LYS ALA LEU GLY ILE SER PRO PHE SEQRES 7 A 115 HIS GLU HIS ALA GLU VAL VAL PHE THR ALA ASN ASP SER SEQRES 8 A 115 GLY PRO ARG ARG TYR THR ILE ALA ALA LEU LEU SER PRO SEQRES 9 A 115 TYR SER TYR SER THR THR ALA VAL VAL THR ASN SEQRES 1 B 115 CYS PRO LEU MET VAL LYS VAL LEU ASP ALA VAL ARG GLY SEQRES 2 B 115 SER PRO ALA ILE ASN VAL ALA VAL HIS VAL PHE ARG LYS SEQRES 3 B 115 ALA ALA ASP ASP THR TRP GLU PRO PHE ALA SER GLY LYS SEQRES 4 B 115 THR SER GLU SER GLY GLU LEU HIS GLY LEU THR THR GLU SEQRES 5 B 115 GLU GLU PHE VAL GLU GLY ILE TYR LYS VAL GLU ILE ASP SEQRES 6 B 115 THR LYS SER TYR TRP LYS ALA LEU GLY ILE SER PRO PHE SEQRES 7 B 115 HIS GLU HIS ALA GLU VAL VAL PHE THR ALA ASN ASP SER SEQRES 8 B 115 GLY PRO ARG ARG TYR THR ILE ALA ALA LEU LEU SER PRO SEQRES 9 B 115 TYR SER TYR SER THR THR ALA VAL VAL THR ASN HET BM8 A 201 17 HET BM8 B 201 17 HETNAM BM8 4-(1,3-BENZOTHIAZOL-2-YL)-2-METHYL-ANILINE FORMUL 3 BM8 2(C14 H12 N2 S) FORMUL 5 HOH *106(H2 O) HELIX 1 AA1 ASP A 74 LEU A 82 1 9 HELIX 2 AA2 ASP B 74 LEU B 82 1 9 SHEET 1 AA1 8 SER A 23 PRO A 24 0 SHEET 2 AA1 8 LEU A 12 ASP A 18 -1 N ASP A 18 O SER A 23 SHEET 3 AA1 8 ARG A 104 SER A 112 1 O ILE A 107 N MET A 13 SHEET 4 AA1 8 SER A 115 THR A 123 -1 O SER A 115 N SER A 112 SHEET 5 AA1 8 SER B 115 THR B 123 -1 O TYR B 116 N THR A 118 SHEET 6 AA1 8 ARG B 104 SER B 112 -1 N SER B 112 O SER B 115 SHEET 7 AA1 8 LEU B 12 ASP B 18 1 N LEU B 17 O LEU B 111 SHEET 8 AA1 8 SER B 23 PRO B 24 -1 O SER B 23 N ASP B 18 SHEET 1 AA2 8 GLU A 54 LEU A 55 0 SHEET 2 AA2 8 LEU A 12 ASP A 18 -1 N VAL A 14 O LEU A 55 SHEET 3 AA2 8 ARG A 104 SER A 112 1 O ILE A 107 N MET A 13 SHEET 4 AA2 8 SER A 115 THR A 123 -1 O SER A 115 N SER A 112 SHEET 5 AA2 8 SER B 115 THR B 123 -1 O TYR B 116 N THR A 118 SHEET 6 AA2 8 ARG B 104 SER B 112 -1 N SER B 112 O SER B 115 SHEET 7 AA2 8 LEU B 12 ASP B 18 1 N LEU B 17 O LEU B 111 SHEET 8 AA2 8 GLU B 54 LEU B 55 -1 O LEU B 55 N VAL B 14 SHEET 1 AA3 8 TRP A 41 LYS A 48 0 SHEET 2 AA3 8 ALA A 29 LYS A 35 -1 N VAL A 32 O ALA A 45 SHEET 3 AA3 8 GLY A 67 ILE A 73 -1 O GLU A 72 N HIS A 31 SHEET 4 AA3 8 HIS A 88 ALA A 97 -1 O ALA A 91 N ILE A 73 SHEET 5 AA3 8 HIS B 88 ALA B 97 -1 O GLU B 89 N VAL A 94 SHEET 6 AA3 8 GLY B 67 ILE B 73 -1 N ILE B 73 O ALA B 91 SHEET 7 AA3 8 ALA B 29 LYS B 35 -1 N HIS B 31 O GLU B 72 SHEET 8 AA3 8 TRP B 41 LYS B 48 -1 O ALA B 45 N VAL B 32 SITE 1 AC1 6 LYS A 15 LEU A 17 ALA A 108 LEU A 110 SITE 2 AC1 6 SER A 117 THR A 119 SITE 1 AC2 7 LYS B 15 LEU B 17 ALA B 108 LEU B 110 SITE 2 AC2 7 SER B 117 THR B 118 THR B 119 CRYST1 42.863 85.509 64.275 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023330 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011695 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015558 0.00000